Emerging mkts attractive, but then... - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Emerging mkts attractive, but then...

Jan 5, 2010

Emerging markets were the talk of the town in 2009. While the developed world was reeling under recession, their emerging counterparts were still growing at an enviable pace. And what is more, the aura of the emerging markets is expected to continue in 2010 too according to Mark Mobius, executive chairman of Templeton Asset Management. In an interview with the Economic Times, Mobius has opined that emerging economies are forecast to grow approximately four times faster than developed economies. This in turn would be reflected in their stock markets.

Not just that, he believes that investors still tend to discount emerging markets as too risky. As a result, valuations in emerging markets are still lower than those of Europe and the US making the former attractive. Further, interest rates in the developed world are at one of their lowest. Therefore, most investors are looking for a better return on their investment. This means that they are putting their money to work in equities in emerging markets.

The interesting thing is what Mobius had to say on valuations of these emerging markets. Already there has been a spectacular rally, most notably in the stockmarkets of Brazil, Russia, India and China. As a result, concerns have already started emanating that valuations here are beginning to look frothy. Valuations at the end of 2009 were certainly not as cheap as they were at the end of 2008. At the same time, Mobius believes that current valuations are around the middle of their historical 10-year range. Therefore, he says, there are opportunities in terms of solid companies that can survive even in a downturn.

We believe that emerging markets have tremendous growth potential from a long term perspective. At the same time for the medium term, valuations do look a tad bit stretched. Hence, investors will have to be all the choosier while picking their stocks. They will have to make sure that they do not pay a very high price even for a strong company.

Big Pharma in an acquisition mode
Big Pharma is at it again! Yes, we are talking about big ticket acquisitions. Hardly had the ink dried on the Pfizer-Wyeth deal, the Swiss drugmaker Novartis has now gone ahead and acquired the remaining stake in Alcon. The latter is the world's largest eye-care company and Novartis has acquired the same for US$ 39.3 bn. The Pfizer-Wyeth deal had taken place at a time when the financial crisis was at its peak. At that time there was growing talk of splitting 'big' companies hit hard by the crisis to make them more transparent and manageable. But that deal and the current Novartis one only highlights that Big Pharma is more concerned about a problem which it considers to be the bigger one - patent expiries of their blockbuster drugs.

Many of the big pharma companies have not really been able to replenish their pipelines at the same pace as in the 90s. Plus, there has been an increasing preference for generics. This has put added pressure on their sales and profits. So on one hand Big Pharma is foraying into generics . And on the other, it is acquiring R&D based companies with a niche focus to fill the product portfolio.

Equitymaster requests your view! Post a comment on "Emerging mkts attractive, but then...". Click here!


More Views on News

How Much Money Should an Investor Set Aside for Trading? (Fast Profits Daily)

Sep 21, 2020

In this video, I'll give you a simple equation which you can use to decide how much money you can set aside for trading.

Kotak Standard Multicap Fund: Strategizing Growth with Focused Approach (Outside View)

Sep 21, 2020

PersonalFN's analysis on the features and performance of Kotak Standard Multicap Fund.

Sensex Can Go to 25,000 Before it Goes to 60,000. Are You Prepared? (Profit Hunter)

Sep 21, 2020

Am I expecting a big crack in the Sensex and what next?

What Do the Charts Say About Buying Smallcaps Now? (Fast Profits Daily)

Sep 18, 2020

Everyone seems to be excited about buying smallcaps now...but is it the right thing to do? What do the charts tell us? Find out in this video...

Sundaram Bluechip Fund: Will Hold the Stable Horses (Outside View)

Sep 18, 2020

PersonalFn briefly outlines the newly launched NFO note HSBC Corporate Bond Fund.

More Views on News

Most Popular

How the 8-Year Cycle Can Help Identify Multibaggers (Fast Profits Daily)

Sep 11, 2020

This is how you can apply the greed and fear cycle in the market to pick stocks.

Why am I Recommending Caution? (Fast Profits Daily)

Sep 9, 2020

This is why I have changed my short-term view on the market.

This Could Be the Best September for Auto Stocks (Profit Hunter)

Sep 11, 2020

Here's why I think this month could be a great for auto stocks.

Why We Picked This Small-cap Stock for Our Hidden Treasure Subscribers (Profit Hunter)

Sep 17, 2020

This leading household brand will profit big time in a post covid world.


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Sep 21, 2020 03:35 PM